JPMorgan Chase teased fans of its Sapphire Reserve premium credit card that a new 2025 version will be out this summer ...

A one-off weight-loss treatment that has been around since the 1950s is far superior than drugs like Ozempic when it comes to ...

Some Ozempic users have reported severe gastrointestinal side effects like stomach paralysis and uncontrollable vomiting.

Some blind vision loss cases have been linked to the use of weight-loss jabs, including Ozempic, so caution is recommended by ...

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

People using Ozempic say they are losing their desire to drink. It’s anecdotal evidence right now, but this would be a game-changer for those who are trying to break free from addiction. Drugs like ...

Patent and trademark enforcement has become an important economic tool for entrepreneurs.

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead ...

An Israeli study has found that patients taking the weekly jab - or similar drugs - were twice as likely to suffer from a ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

BALTIMORE — The Circuit Court for Baltimore City is temporarily pausing all civil lawsuits filed under Maryland's Child Victims Act (CVA). In October 2023, the Maryland General Assembly passed the CVA ...